Baxter falls on downbeat 2026 profit forecast
** Shares of medical device maker Baxter International BAX.N fall 16% to $18.64 premarket ** Co forecasts 2026 profit in the range of $1.85 and $2.05 per share, below analysts' average estimate of $2.25, according to data compiled by LSEG ** BAX reports Q4 adj. EPS of 36 cents, falling far short of estimates of 54 cents ** Co posts Q4 revenue of $2.97 billion, vs est of $2.82 billion ** BAX stock slumped 34% in 2025 (Reporting by Padmanabhan Ananthan) ((Padmanabhan.Ananthan@thomsonreuters.com))
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers